Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe C-reactive Protein Testing Market, by Application
1.4.2 Europe C-reactive Protein Testing Market, by Assay Type
1.4.3 Europe C-reactive Protein Testing Market, by End User
1.4.4 Europe C-reactive Protein Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Europe C-reactive Protein Testing Market by Application
4.1 Europe Cardiovascular Disease Market by Country
4.2 Europe Inflammatory Bowel Disease Market by Country
4.3 Europe Rheumatoid Arthritis Market by Country
4.4 Europe Diabetes Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe C-reactive Protein Testing Market by Assay Type
5.1 Europe Immunoturbidimetric Assays Market by Country
5.2 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
5.3 Europe Chemiluminescence Immunoassay (CLIA) Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe C-reactive Protein Testing Market by End User
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Diagnostic Laboratories Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe C-reactive Protein Testing Market by Country
7.1 Germany C-reactive Protein Testing Market
7.1.1 Germany C-reactive Protein Testing Market by Application
7.1.2 Germany C-reactive Protein Testing Market by Assay Type
7.1.3 Germany C-reactive Protein Testing Market by End User
7.2 UK C-reactive Protein Testing Market
7.2.1 UK C-reactive Protein Testing Market by Application
7.2.2 UK C-reactive Protein Testing Market by Assay Type
7.2.3 UK C-reactive Protein Testing Market by End User
7.3 France C-reactive Protein Testing Market
7.3.1 France C-reactive Protein Testing Market by Application
7.3.2 France C-reactive Protein Testing Market by Assay Type
7.3.3 France C-reactive Protein Testing Market by End User
7.4 Russia C-reactive Protein Testing Market
7.4.1 Russia C-reactive Protein Testing Market by Application
7.4.2 Russia C-reactive Protein Testing Market by Assay Type
7.4.3 Russia C-reactive Protein Testing Market by End User
7.5 Spain C-reactive Protein Testing Market
7.5.1 Spain C-reactive Protein Testing Market by Application
7.5.2 Spain C-reactive Protein Testing Market by Assay Type
7.5.3 Spain C-reactive Protein Testing Market by End User
7.6 Italy C-reactive Protein Testing Market
7.6.1 Italy C-reactive Protein Testing Market by Application
7.6.2 Italy C-reactive Protein Testing Market by Assay Type
7.6.3 Italy C-reactive Protein Testing Market by End User
7.7 Rest of Europe C-reactive Protein Testing Market
7.7.1 Rest of Europe C-reactive Protein Testing Market by Application
7.7.2 Rest of Europe C-reactive Protein Testing Market by Assay Type
7.7.3 Rest of Europe C-reactive Protein Testing Market by End User
Chapter 8. Company Profiles
8.1 Danaher Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Abbott Laboratories
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Horiba Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Randox Laboratories Limited
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Zoetis, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Quest Diagnostics Incorporated
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 SWOT Analysis
8.9 Laboratory Corporation of America Holdings
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 SWOT Analysis
8.10. Merck KGaA
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Unique Offerings 